Monoclonal antibodies revolutionized medicine by introducing a range of targeted therapies against malignant diseases, autoimmune disorders, infectious diseases, and many others. They are engineered from a single clone of cells to bind to antigens with very high precision. This article presents the underlying science behind monoclonal antibodies, including their applications, […]

GLP is a formal regulation created by the USFDA as these regulations were proposed on November 19, 1976, and designated as a new part of Chapter 21 of the Code of Federal Regulations (CFR) as 21 CFR Part 58 in 1979. In 1981 an organization named OECD (Organization for Economic Cooperation and Development) produced GLP principles that are international standards.

The basis of the randomly amplified polymorphic DNA (RAPD) technique is differential PCR amplification of genomic DNA. It uses short random oligonucleotide sequences (usually 10 bases long) to infer DNA polymorphisms caused by “rearrangements or deletions at or between oligonucleotide primer binding sites in the genome.”

Restriction fragment length polymorphism markers were the first DNA-based genetic markers developed. The size of eukaryotic genomes hindered a simple identification of genetic variations in specific genes or sequences. The capability of complementary base pairing to reveal polymorphisms in sequences homologous to the probe enabled the development of methods to […]

Skip to content